Jeremy Grantham's VNDA Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 21,737 shares of Vanda Pharmaceuticals Inc. (VNDA) worth $106,729, representing 0.00% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in VNDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 146,600 shares. Largest reduction occurred in Q4 2020, reducing 122,700 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Vanda Pharmaceuticals (VNDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanda Pharmaceuticals (VNDA) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -6,607 | Reduce 23.31% | 21,737 | $4.91 |
| Q2 2026 | +12,022 | Add 73.66% | 28,344 | $6.12 |
| Q1 2026 | +16,322 | New Buy | 16,322 | $6.91 |
| Q4 2021 | -13,100 | Sold Out | 0 | $0.00 |
| Q3 2021 | +13,100 | New Buy | 13,100 | $17.18 |
| Q1 2021 | -14,600 | Sold Out | 0 | $0.00 |
| Q4 2020 | -122,700 | Reduce 89.37% | 14,600 | $13.15 |
| Q3 2020 | -29,300 | Reduce 17.59% | 137,300 | $9.66 |
| Q2 2020 | +146,600 | Add 733.00% | 166,600 | $11.44 |
| Q1 2020 | +20,000 | New Buy | 20,000 | $10.35 |
Jeremy Grantham's Vanda Pharmaceuticals Investment FAQs
Jeremy Grantham first purchased Vanda Pharmaceuticals Inc. (VNDA) in Q1 2020, acquiring 20,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Vanda Pharmaceuticals Inc. (VNDA) for 10 quarters since Q1 2020.
Jeremy Grantham's largest addition to Vanda Pharmaceuticals Inc. (VNDA) was in Q2 2020, adding 166,600 shares worth $1.91 M.
According to the latest 13F filing for Q3 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 21,737 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $106,729.
As of the Q3 2026 filing, Vanda Pharmaceuticals Inc. (VNDA) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Vanda Pharmaceuticals Inc. (VNDA) was 166,600 shares, as reported at the end of Q2 2020.